- NCT00000131
Central Vein Occlusion Study (CVOS)
Phase 3Completed - NCT00000132
Early Manifest Glaucoma Trial (EMGT)
Phase 3Unknown - NCT00000152
Randomized Trial of Beta-Carotene and Macular Degeneration
Phase 3Unknown - NCT00000170
Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia
Phase 3Completed - NCT00000169
The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study
Unknown - NCT00000158
Macular Photocoagulation Study (MPS)
Phase 3Unknown - NCT00000118
Ganciclovir Implant Study for Cytomegalovirus Retinitis
Phase 3Completed - NCT00000133
Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity
Not ApplicableCompleted - NCT00000119
Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
Phase 2Unknown - NCT00000125
Ocular Hypertension Treatment Study (OHTS)
Phase 3Completed - NCT00000151
Early Treatment Diabetic Retinopathy Study (ETDRS)
Phase 3Completed - NCT00000156
The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)
Phase 3Completed - NCT00000150
Submacular Surgery Trials (SST)
Phase 3Completed - NCT00000120
Clinical Trial of Eye Prophylaxis in the Newborn
Phase 3Completed - NCT00000127
Ischemic Optic Neuropathy Decompression Trial (IONDT)
Phase 3Completed - NCT00000148
Advanced Glaucoma Intervention Study (AGIS)
Phase 3Unknown - NCT00000113
Correction of Myopia Evaluation Trial (COMET)
Phase 3Completed - NCT00000155
The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study
Unknown - NCT00000250
Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
Phase 2Completed - NCT00000281
Pharmacotherapy for Schizophrenic Drug Users - 6
Phase 2Completed - NCT00000282
Pemoline for Cocaine Abuse - 7
Phase 2Completed - NCT00000284
Role of Metabolites in Nicotine Dependence (1) - 1
Phase 2Completed - NCT00000249
Effects of Subanesthetic Concentrations of Nitrous Oxide - 1
Phase 2Completed - NCT00000198
Piracetam for Treatment of Cocaine Addiction - 3
Phase 1Completed - NCT00000199
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
Phase 1Withdrawn - NCT00000285
Effects of Phenytoin on Cocaine Use in Humans - 2
Phase 1Completed - NCT00000286
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
Phase 2Completed - NCT00000336
Selegiline in Outpatient Treatment for Cocaine Dependence - 1
Phase 2Completed - NCT00000287
Relapse Patterns in Female Cocaine Users - 4
Completed - NCT00000248
Dose Response Trial of Pergolide for Cocaine Dependence - 1
Phase 3Completed - NCT00000288
Role of Metabolites in Nicotine Dependence (2) - 5
Phase 2Completed - NCT00000246
Rapid Benzodiazepine Detoxification Using Flumazenil - 1
Phase 2Completed - NCT00000289
Role of Metabolites in Nicotine Dependence (3) - 6
Phase 2Completed - NCT00000290
Stress Hormones and Human Cocaine Use - 7
Phase 1Completed - NCT00000245
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
Phase 2Completed - NCT00000291
Effects of Labetalol on Human Cocaine Use - 8
Phase 2Completed - NCT00000292
Acute Withdrawal From Smoked Cocaine - 9
Phase 1Completed - NCT00000293
Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
Phase 3Completed - NCT00000294
Effects of Carvedilol on Cocaine Use in Humans - 11
Phase 2Completed - NCT00000295
Progesterone Treatment in Female Smokers - 12
Phase 2Completed - NCT00000296
Role of Metabolites in Nicotine Dependence (4) - 13
Phase 2Completed - NCT00000244
Effects of Dynorphin 1-13 on Heroin Addiction - 1
Phase 2Completed - NCT00000194
Neurobiology of Opioid Dependence: 3 - 3
Phase 2Withdrawn - NCT00000297
Effects of Labetalol on Nicotine Administration in Humans - 14
Phase 2Completed - NCT00000187
Ritanserin in Treatment of Cocaine Dependence - 1
Phase 2Completed - NCT00000298
Buprenorphine Combination Tablet Feasibility - 1
Phase 2Completed - NCT00000189
Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
Phase 2Completed - NCT00000337
Infusion Laboratory: Protocol 1 - Selegeline - 2
Phase 1Completed - NCT00000357
Buprenorphine Maintenance for Opiate Dependence - 6
Phase 2Completed - NCT00000299
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
Phase 2Completed - NCT00000260
Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12
Not ApplicableCompleted - NCT00000243
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
Not ApplicableTerminated - NCT00000330
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
Phase 2Withdrawn - NCT00000352
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Phase 2Completed - NCT00000300
Feasibility Study of Take-Home LAAM Medication - 3
Phase 4Completed - NCT00000301
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
Phase 2Completed - NCT00000302
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
Phase 3Completed - NCT00000303
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
Phase 2Completed - NCT00000305
Amphetamine Cocaine Interaction Study - 2
Phase 1Terminated - NCT00000188
Selegiline in Treatment of Cocaine Dependence - 2
Phase 2Completed - NCT00000242
Carbamazepine Treatment of Cocaine Dependence - 1
Phase 2Completed - NCT00000306
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
Phase 2Completed - NCT00000307
Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
Phase 2Completed - NCT00000309
Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
Phase 2Terminated - NCT00000200
Cocaine Effects in Humans: Physiology and Behavior - 1
Phase 2Completed - NCT00000310
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
Phase 2Terminated - NCT00000241
Flupenthixol Decanoate in Methamphetamine Smoking - 1
Phase 2Completed - NCT00000311
Combining Behavioral Treatment With Agonist Maintenance - 1
Phase 3Completed - NCT00000351
Cognitive Correlates of Substance Abuse, Part 2 - 16
Unknown - NCT00000312
Alterations in Serotonergic Functions in Cocaine Addicts - 1
Phase 1Completed - NCT00000313
Predictive Values of Serotonergic Alterations for Outcome - 2
Phase 1Terminated - NCT00000332
High Dose Nimodipine Treatment Adjunct - 1
Phase 2Completed - NCT00000314
M-CPP and Fenfluramine in Cocaine Addicts - 3
Phase 2Completed - NCT00000346
Cognitive Correlates of Substance Abuse - 11
Phase 4Unknown - NCT00000240
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
Phase 2Completed - NCT00000315
Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
Phase 1Completed - NCT00000333
Evaluation of Benztropine for Cocaine Craving - 2
Phase 2Completed - NCT00000201
Pharmacological Modulation of Cocaine Effects - 1
Phase 2Completed - NCT00000239
Buprenorphine Pharmacology Related to Addiction Treatment - 21
Phase 2Completed - NCT00000358
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Phase 1Completed - NCT00000350
Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
Phase 1Unknown - NCT00000316
Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2
Phase 1Completed - NCT00000238
Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
Phase 2Completed - NCT00000237
Buprenorphine Detoxification - BBDVI - 19
Phase 2Completed - NCT00000236
Buprenorphine Pharmacology Related to Addiction Treatment - 18
Phase 2Completed - NCT00000318
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Phase 2Completed - NCT00000235
Alternate Day Buprenorphine Administration, Phase XII - 17
Phase 2Completed - NCT00000234
Alternate Day Buprenorphine Administration, Phase XI - 16
Phase 2Completed - NCT00000349
Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
Phase 1Unknown - NCT00000233
Alternate Day Buprenorphine Administration, Phase X - 15
Phase 2Completed - NCT00000202
Buprenorphine Maintenance for Opioid Addicts - 1
Phase 2Completed - NCT00000232
Alternate Day Buprenorphine Administration, Phase IX - 14
Phase 2Completed - NCT00000231
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
Phase 2Completed - NCT00000353
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Phase 2Completed - NCT00000230
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
Phase 2Completed - NCT00000229
Buprenorphine Detox With Two Types of Treatment. BBD II - 11
Phase 2Completed - NCT00000319
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
Phase 2Completed - NCT00000228
Buprenorphine Detox With Two Types of Treatment. BBD I - 10
Phase 2Completed - NCT00000348
Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
Phase 1Unknown - NCT00000227
Alternate-Day Buprenorphine Administration. Phase VIII - 9
Phase 2Completed